Surgical management of multi-organ visceral tumors in patients with von Hippel-Lindau disease: a single stage approach.

PURPOSE We assessed surgical feasibility of a 1-stage multi-organ approach for multiple visceral tumors in patients with von Hippel-Lindau disease. MATERIALS AND METHODS A total of 14 men and 15 women with von Hippel-Lindau disease underwent simultaneous multi-organ surgery for multiple adrenal, renal and pancreatic tumors at the National Cancer Institute between 1988 and 2001. Perioperative and followup data were analyzed retrospectively. The Mann-Whitney U test was used for statistical analysis. RESULTS Surgery involving 2 or more organs (mean 2.4 procedures per patient, range 2 to 4) was performed in all patients and concurrent pancreatic operations were performed in 12 (41%). Overall a combined 71 procedures, were performed including 4 cases (13%) treated laparoscopically. Mean +/- SD operative time and estimated blood loss were 464 +/- 142 minutes (range 206 to 830) and 2,798 +/- 4,285 cc (300 to 20,000), respectively. In 16 patients (55%) blood transfusion was administered intraoperatively. At a median followup of 21 months (range 5 to 151) renal tumors recurred in 8 patients (28%), requiring further kidney operations, but no patient had pancreatic or adrenal recurrence. The overall complication rate was 38%, and there was no operative mortality. CONCLUSIONS A single stage surgical approach for multi-organ visceral tumors is a viable option for patients with von Hippel-Lindau disease. With careful patient selection and surgical planning combined procedures can be safely performed in 1 operative setting.

[1]  J. Norton,et al.  Comparison of Surgical Results in Patients With Advanced and Limited Disease With Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndrome , 2001, Annals of surgery.

[2]  P L Choyke,et al.  Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. , 2001, The Journal of urology.

[3]  H. Neumann,et al.  Laparoscopic surgery for pheochromocytoma. , 2001, The Urologic clinics of North America.

[4]  S. Libutti,et al.  Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease. , 2000, Surgery.

[5]  S. Libutti,et al.  Clinical and genetic analysis of patients with pancreatic neuroendocrine tumours associated with von Hippel‐Lindau disease , 2000 .

[6]  P. Choyke,et al.  Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. , 1999, The Journal of urology.

[7]  P. Choyke,et al.  Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy. , 1999, The Journal of urology.

[8]  S. Libutti,et al.  Operative management of islet-cell tumors arising in the head of the pancreas. , 1998, Surgery.

[9]  S K Libutti,et al.  Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. , 1998, Surgery.

[10]  S. Libutti,et al.  Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. , 1998, The American journal of pathology.

[11]  Goldfarb Nephron‐sparing surgery and renal transplantation in patients with renal cell carcinoma and von Hippel–Lindau disease , 1998, Journal of internal medicine.

[12]  P. Choyke,et al.  Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. , 1997, JAMA.

[13]  J. Richie,et al.  Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. , 1995, The Journal of urology.

[14]  Richard D. Williams,et al.  Conservative surgical therapy of localized renal cell carcinoma in von hippel‐lindau disease , 1994, Cancer.

[15]  D. Hough,et al.  Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. , 1994, AJR. American journal of roentgenology.

[16]  S. Richard,et al.  Renal lesions and pheochromocytoma in von Hippel-Lindau disease. , 1994, Advances in nephrology from the Necker Hospital.

[17]  J. Gnarra,et al.  Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.

[18]  H. Brambs,et al.  Pancreatic lesions in the von Hippel-Lindau syndrome. , 1991, Gastroenterology.

[19]  M. Ferguson-Smith,et al.  Clinical features and natural history of von Hippel-Lindau disease. , 1990, The Quarterly journal of medicine.

[20]  Hsia Ye,et al.  von Hippel-Lindau disease affecting 43 members of a single kindred. , 1989 .

[21]  J. Haines,et al.  Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma , 1988, Nature.

[22]  J. Coombs,et al.  Metastatic islet cell tumor in von Hippel-Lindau disease. , 1984, The American journal of medicine.